ON Semiconductor Corp. (NASDAQ:ONNN) reported net income of $41.6 million in its third quarter. The Phoenix-based company said it had profit of 9 cents per share. Earnings, adjusted for one-time gains and costs, were 21 cents per share. ON Semiconductor Corp. (NASDAQ:ONNN) belongs to Technology sector. Its net profit margin is 7.80% and weekly performance is 4.28%. On last trading day company shares ended up $8.29. ON Semiconductor Corp. (NASDAQ:ONNN) distance from 50-day simple moving average (SMA50) is -6.60%. Trimble Navigation Limited (NASDAQ:TRMB)‘s stock had its “neutral” rating reaffirmed by Zacks in a research note issued to investors on Friday. They currently have a $32.00 price objective on the stock. Zacks‘s price target suggests a potential upside of 5.16% from the stock’s previous close. Trimble Navigation Limited (NASDAQ:TRMB) shares fell -11.73% in last trading session and ended the day at $26.86. TRMB Gross Margin is 53.90% and its return on assets is 7.00%. Trimble Navigation Limited (NASDAQ:TRMB) quarterly performance is -14.38%. On Oct 23, Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) announced the appointment of industry veteran Wendy L. Dixon, PhD, former Chief Marketing Officer and President of Global Marketing for Bristol Myers Squibb, to the company’s Board of Directors. On 31 October, Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) shares fell -2.49% and was closed at $10.56. EBIO EPS growth in last 5 year was 0.00%. Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) year to date (YTD) performance is -2.67%. Twitter Inc (NYSE:TWTR) appointed Kevin Weil head of product, broadening his responsibilities and shifting another executive into a different role as part of the change, said a person with knowledge of the matter. Twitter Inc (NYSE:TWTR) belongs to Technology sector. Its net profit margin is -87.60% and weekly performance is -16.98%. On last trading day company shares ended up $41.47. Twitter Inc (NYSE:TWTR) distance from 50-day simple moving average (SMA50) is -17.29%. The U.S. Federal Trade Commission, or FTC, on Friday cleared Actavis plc (NYSE:ACT)pending acquisition of Durata Therapeutics Inc. (DRTX). The FTC granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to the deal. Actavis plc (NYSE:ACT) shares moved down -0.19% in last trading session and ended the day at $242.74. ACT Gross Margin is 49.10% and its return on assets is 0.30%. Actavis plc (NYSE:ACT) quarterly performance is 12.50%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
